Internal Medicine, Medical Oncology · Houston, TX
NPI
1184745739
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
415 services
Medicare patients, 2024
173
Average age 70
Drug cost, 2024
$1.7M
269 prescriptions
Company payments, 2025
$548
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony P Conley was code 99214 (office e&m - established), 160 times for 82 patients. In total Anthony P Conley billed 415 services in 17 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 160 | 82 | $75.03 | $12K |
| 99215 Office E&M - Established | Facility | 104 | 52 | $112.90 | $12K |
| 99213 Office E&M - Established | Facility | 37 | 33 | $51.54 | $1,907 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $137.57 | $2,614 |
| 99205 Office E&M - New | Facility | 16 | 16 | $145.42 | $2,327 |
| 99204 Office E&M - New | Facility | 12 | 12 | $106.57 | $1,279 |
By year: 2022 $52K for 599 services; 2023 $39K for 466 services; 2024 $37K for 415 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anthony P Conley prescribed most often to Medicare patients was Imatinib Mesylate, with 24 prescriptions and refills. In total Anthony P Conley wrote 269 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 24 | 30 | Under 11 | $58K |
| Lactated Ringers Ringer's Solution,lactated | 18 | 18 | Under 11 | $2,136 |
| Gleevec Imatinib Mesylate | 18 | 24 | Under 11 | $240K |
| Ondansetron Hcl Generic | 16 | 16 | 13 | $57.92 |
| Stivarga Regorafenib | 15 | 15 | Under 11 | $277K |
| Gilotrif Afatinib Dimaleate | 14 | 14 | Under 11 | $151K |
| Inlyta Axitinib | 14 | 14 | Under 11 | $264K |
| Dexamethasone Generic | 13 | 13 | Under 11 | $174 |
| Tazverik Tazemetostat Hydrobromide | 12 | 12 | Under 11 | $225K |
| Prochlorperazine Maleate Generic | 11 | 11 | Under 11 | $128 |
Brand drugs: 124 claims; generic drugs: 145 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony P Conley $548 ($548 in general payments such as food, travel and fees) from 5 companies. The largest payer was icotec Medical Inc. with $468.
| Company | Payments | Amount |
|---|---|---|
| icotec Medical Inc. | 9 | $468 |
| Servier BioInnovation | 1 | $64.84 |
| Deciphera Pharmaceuticals Inc. | 1 | $15.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.